Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.97 - $5.2 $193,768 - $339,258
-65,242 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$4.99 - $7.46 $325,557 - $486,705
65,242 New
65,242 $326,000
Q2 2021

Aug 16, 2021

SELL
$6.23 - $10.03 $90,958 - $146,438
-14,600 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$8.81 - $16.96 $128,626 - $247,616
14,600 New
14,600 $135,000
Q4 2017

Feb 01, 2018

SELL
$4.13 - $6.68 $76,405 - $123,580
-18,500 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$5.36 - $6.37 $99,160 - $117,845
18,500
18,500 $117,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $494M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.